newsfilter
← Latest News
PR Newswire·

Medivir to present updated clinical data for fostrox + Lenvima in HCC at ESMO Conference in September

Medivir AB (NASDAQ: MVIR) (STOCKHOLM: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...